VN

Veera Nagamani Karakavalasa

Active Director Director DIN 09832694
DIN 09832694 First appointment Dec 2022 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Veera Nagamani Karakavalasa

Data last updated:

Veera Nagamani Karakavalasa is a Director at Atemreinn Pharmaceuticals Private Limited (since 2022). The company operates in Chemicals.

DIN 09832694
Primary Designation Director
Industry Chemicals
First Appointment 21 Dec 2022
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 Dec 20222022Active

Board colleagues of Veera Nagamani Karakavalasa

NameDINCompanyDesignation
Kanaka Durga Limmala09832693Atemreinn Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Atemreinn Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Veera Nagamani Karakavalasa

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Veera Nagamani Karakavalasa

Veera Nagamani Karakavalasa currently holds 1 directorship: Atemreinn Pharmaceuticals Private Limited (Director, since 21 Dec 2022).

Veera Nagamani Karakavalasa was first appointed on 21 Dec 2022 as Director at Atemreinn Pharmaceuticals Private Limited.

The current boards of Veera Nagamani Karakavalasa's companies include Kanaka Durga Limmala (Atemreinn Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available